Literature DB >> 12946604

Urinary dopamine and turn bias in traumatized women with and without PTSD symptoms.

Dorie A Glover1, Mark B Powers, Lyndsey Bergman, Jasper A J Smits, Michael J Telch, Margaret Stuber.   

Abstract

Turning biases are known to occur in the direction of the brain hemisphere with decreased dopamine (DA). Although elevations in urinary DA have been shown in posttraumatic stress disorder (PTSD), evidence for dysregulation of dopaminergic activity in the brain is lacking. Turn bias and urinary DA levels were examined in mothers of childhood cancer survivors. As expected, cancer trauma mothers with PTSD symptoms (n=14) had higher urinary DA levels than trauma mothers without PTSD symptoms (n=7) and controls (n=8) (P=0.01). Groups were also significantly different in prevalence of left turn bias (P=0.03). All controls (100%) showed a left turn bias compared to 75 and 37.5% prevalence among trauma mothers with and without PTSD, respectively. Urinary DA levels and turn bias rates were not correlated. Results lend support for further exploration of DA in traumatized groups with and without PTSD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946604     DOI: 10.1016/s0166-4328(03)00074-3

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  13 in total

1.  Dopamine in the nucleus accumbens modulates the memory of social defeat in Syrian hamsters (Mesocricetus auratus).

Authors:  C L Gray; A Norvelle; T Larkin; K L Huhman
Journal:  Behav Brain Res       Date:  2015-02-23       Impact factor: 3.332

Review 2.  Genetics of anxiety and trauma-related disorders.

Authors:  S D Norrholm; K J Ressler
Journal:  Neuroscience       Date:  2009-06-18       Impact factor: 3.590

Review 3.  Ventral Tegmental Area Dysfunction and Disruption of Dopaminergic Homeostasis: Implications for Post-traumatic Stress Disorder.

Authors:  Peiling Zhou; Meiping Deng; Jiashan Wu; Qinghui Lan; Huifang Yang; Changzheng Zhang
Journal:  Mol Neurobiol       Date:  2021-01-11       Impact factor: 5.590

4.  Genotype-controlled analysis of serum dopamine β-hydroxylase activity in civilian post-traumatic stress disorder.

Authors:  Yi-lang Tang; Wenbiao Li; Kristina Mercer; Bekh Bradley; Charles F Gillespie; Robert Bonsall; Kerry J Ressler; Joseph F Cubells
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-08-22       Impact factor: 5.067

5.  Allostatic load in women with and without PTSD symptoms.

Authors:  Dorie A Glover; Margaret Stuber; Russell E Poland
Journal:  Psychiatry       Date:  2006       Impact factor: 2.458

6.  Preliminary evidence for lymphocyte distribution differences at rest and after acute psychological stress in PTSD-symptomatic women.

Authors:  Dorie A Glover; Amber C Steele; Margaret L Stuber; John L Fahey
Journal:  Brain Behav Immun       Date:  2005-05       Impact factor: 7.217

7.  Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [(99m)Tc]TRODAT-1.

Authors:  Marcelo Q Hoexter; Gustavo Fadel; André C Felício; Mariana B Calzavara; Ilza R Batista; Marilia A Reis; Ming C Shih; Roger K Pitman; Sérgio B Andreoli; Marcelo F Mello; Jair J Mari; Rodrigo A Bressan
Journal:  Psychopharmacology (Berl)       Date:  2012-06-15       Impact factor: 4.530

8.  Posttraumatic stress disorder among women after the war in Sarajevo: a rationale for genetic study.

Authors:  Lilijana Oruc; Lejla Kapur; Naris Pojskić; Semra Cavaljuga; Sladjana Ivezić; Pamela Bell
Journal:  Bosn J Basic Med Sci       Date:  2004-02       Impact factor: 3.363

Review 9.  Untangling PTSD and TBI: Challenges and Strategies in Clinical Care and Research.

Authors:  Rebecca C Hendrickson; Abigail G Schindler; Kathleen F Pagulayan
Journal:  Curr Neurol Neurosci Rep       Date:  2018-11-08       Impact factor: 5.081

Review 10.  Peripheral Biomarker Candidates of Posttraumatic Stress Disorder.

Authors:  Hee Jin Kang; Sujung Yoon; In Kyoon Lyoo
Journal:  Exp Neurobiol       Date:  2015-09-22       Impact factor: 3.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.